Literature DB >> 32011624

Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary.

William B Feldman1,2,3, Benjamin N Rome1,3, Lisa Soleymani Lehmann3,4,5, Aaron S Kesselheim1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32011624      PMCID： PMC7042836          DOI： 10.1001/jamainternmed.2019.7018

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  2 in total

1.  Assessment of Spending in Medicare Part D If Medication Prices From the Department of Veterans Affairs Were Used.

Authors:  Brett Venker; Kevin B Stephenson; Walid F Gellad
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

2.  Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined Formulary.

Authors:  William B Feldman; Jerry Avorn; Aaron S Kesselheim
Journal:  JAMA Intern Med       Date:  2020-03-01       Impact factor: 21.873
  2 in total
  1 in total

1.  Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitors.

Authors:  Alvaro San-Juan-Rodriguez; Vincent M Piro; Chester B Good; Walid F Gellad; Inmaculada Hernandez
Journal:  J Manag Care Spec Pharm       Date:  2021-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.